Send to

Choose Destination
See comment in PubMed Commons below
Curr Drug Targets. 2004 Jan;5(1):57-69.

Vaccine development for group A streptococcus infections and associated disease.

Author information

  • 1Cooperative Research Centre for Vaccine Technology, The Australian Centre for International Tropical Health and Nutrition, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane 4029, Australia.


Group A streptococcus (GAS) is responsible for a number of diseases ranging from uncomplicated pharyngitis through to life-treating invasive and post-infectious diseases such as necrotizing fasciitis and rheumatic heart disease. GAS associated diseases occur globally and are serious problems in many developing nations and indigenous populations of many developed nations. This, and the resurgence in industrialized countries, and increased virulence of GAS in the 1980s highlight the need of cost-effective control strategies. Here we highlight the GAS diseases that are still a problem in many populations and discuss potentially useful strategies to combat GAS infections and disease.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center